Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, Mounjaro. CEO David Ricks is optimistic about India’s growth potential and highlights the transformative power of innovative medicines alongside generics in managing public health.
State Bank of India (SBI) recorded its highest-ever net profit of Rs 18,331 crore in the September quarter, marking a 28% surge. This achievement was […]
LVMH, the world’s largest luxury conglomerate, reported a 3% decline in third-quarter sales, falling short of estimates due to weakened demand in China and Japan. […]
India’s eight core infrastructure sectors showed a slowed growth of 4.3% in November 2024, down from 7.9% in the previous year. However, monthly production hit […]
